A comprehensive dry eye evaluation is designed to determine whether you have dry eye disease, identify the factors driving the condition and develop a treatment plan based on your individual findings.
The evaluation includes much more than checking whether your eyes produce enough tears. It examines your symptoms, tear film stability, eyelids, meibomian glands, ocular surface, medical history, medications and other factors that may be affecting your eyes.
At EnVision Dry Eye Center, Dr. Jason Besecker uses detailed clinical examination and objective diagnostic testing to understand why your eyes are uncomfortable, watery or visually unstable. Not every patient receives exactly the same tests. The evaluation is tailored to your symptoms, history and examination findings.
Dry eye is a multifactorial disease. Two patients can report similar burning, grittiness or fluctuating vision while having very different underlying problems.
Current TFOS DEWS III guidance defines dry eye as a symptomatic disease involving loss of homeostasis of the tear film and/or ocular surface. Tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities may all contribute.
A comprehensive evaluation therefore has two main purposes:
These drivers may include tear-component deficiencies, eyelid abnormalities, ocular surface abnormalities, systemic conditions, medication use, environmental exposure or a combination of factors.
Learn more: What Causes Dry Eye?
The evaluation begins with a detailed discussion of your symptoms and health history.
Dr. Besecker may ask about:
You may also be asked to complete a standardized symptom questionnaire. TFOS DEWS III recommends the Ocular Surface Disease Index-6, or OSDI-6, as a concise way to document symptoms and how they affect daily activities.
A questionnaire is only one part of the evaluation. Your answers must be considered together with the examination and objective test results.
Healthy eyelids are essential for maintaining a stable tear film. Each blink spreads tears across the eye, distributes oil from the meibomian glands and helps clear debris from the ocular surface.
The eyelid examination may assess:
Eyelid abnormalities can destabilize the tear film even when tear production appears adequate.
Related answers:
Some measurements need to be performed before dyes or eye drops are placed in the eyes because these substances can temporarily change the tear film. Testing is generally arranged from least invasive to more invasive.
Depending on your symptoms and examination findings, testing at EnVision Dry Eye Center may include the following.
Tear osmolarity measures the concentration of the tears. When the tear film becomes unstable or excessive water evaporates, the remaining tears may become more concentrated.
Elevated or unequal osmolarity measurements can indicate loss of tear film homeostasis. The results are interpreted alongside your symptoms and other clinical findings rather than being used as a stand-alone diagnosis.
Noninvasive tear breakup time measures how long the tear film remains stable between blinks without first placing fluorescein dye in the eye.
A tear film that breaks apart too quickly can expose areas of the ocular surface between blinks. This can contribute to burning, irritation, reflex tearing and fluctuating vision.
The measurement may also reveal whether blinking temporarily restores visual clarity.
Learn more: Why Does Dry Eye Cause Blurry or Fluctuating Vision?
Meibography produces images of the meibomian glands located within the eyelids. These glands create the oils that slow tear evaporation and help maintain tear-film stability.
Meibography can identify structural changes, shortening or loss of the glands that may not be visible during a routine eye examination.
The images must be interpreted together with the appearance of the eyelid margins and the quality and expressibility of the gland secretions. Gland structure alone does not provide a complete assessment of meibomian gland function.
Fluorescein is a diagnostic dye used to evaluate tear-film breakup and identify areas of corneal or conjunctival disruption.
The pattern, location and severity of staining can provide clues about the factors affecting the ocular surface. For example, different patterns may be associated with tear film instability, exposure during sleep, eyelid abnormalities, contact lens wear or other ocular surface conditions.
A slit lamp allows the eyelids, eyelashes, tear film, cornea and conjunctiva to be examined under high magnification.
High resolution imaging documents important findings and allows changes to be compared over time. Images may show eyelid margin inflammation, tear film debris, corneal staining, conjunctival abnormalities or other findings that help explain a patient’s symptoms.
Not every patient needs the same testing. Additional evaluation may be appropriate when symptoms suggest:
Corneal sensation or lacrimal drainage may be evaluated when the history and clinical findings indicate that these systems could be contributing.
After determining whether dry eye is present, Dr. Besecker evaluates the factors driving the disease.
TFOS DEWS III organizes these drivers into several major categories.
The tear film contains several interacting components. Testing may identify abnormalities involving:
A patient may have a deficiency involving one or several tear components.
Eyelid related drivers may include:
Because blinking and eyelid function directly affect tear distribution and evaporation, eyelid abnormalities frequently contribute to dry eye.
Ocular surface drivers may include:
The evaluation also considers factors beyond the eye, including:
These categories are not mutually exclusive. Many patients have several interacting drivers that need to be addressed together.
No. A comprehensive evaluation does not mean that every available test must be performed on every patient.
Testing is selected according to your symptoms, medical history, previous treatment response and examination findings. One patient may require a detailed meibomian gland and eyelid assessment, while another may need greater attention to aqueous tear production, corneal staining, eyelid closure or neurosensory function.
The goal is to gather enough meaningful information to establish the diagnosis and identify the most important treatment targets not to perform testing that will not affect clinical decisions.
The severity of dry eye symptoms does not always match the amount of visible ocular surface damage.
A patient may experience intense burning, light sensitivity or pain despite having relatively limited staining or inflammation. In some cases, this symptom sign mismatch may suggest abnormal corneal nerve signaling or a neuropathic component.
The opposite can also occur. A patient may have significant corneal staining with surprisingly little discomfort. Reduced corneal sensation or neurotrophic keratitis may need to be considered.
This is one reason a comprehensive evaluation includes the patient’s symptom history as well as objective clinical findings. Neither symptoms nor testing should be interpreted in isolation.
After the examination, Dr. Besecker will review the findings with you and explain:
Your treatment plan may combine daily home care, prescription medications, tear film support and in office procedures. Recommendations are based on the identified drivers, disease severity, previous treatment response and your individual goals.
Because dry eye is frequently chronic and multifactorial, treatment may be adjusted over time as the ocular surface responds.
The initial priority is to establish an accurate diagnosis and identify the factors contributing to your condition.
Some treatments or home care recommendations may be started after the initial evaluation. Other procedures may be scheduled separately after the test results, treatment options, expected benefits and alternatives have been discussed.
Treatment is not automatically based on a predetermined sequence. It is selected according to your individual findings.
To help make the evaluation as useful as possible:
Do not discontinue prescribed eye drops or medications unless your prescribing clinician or EnVision Dry Eye Center has instructed you to do so.
Dry eye treatments may provide little or only temporary improvement when they do not address the primary etiological drivers.
For example, artificial tears may add temporary lubrication but will not correct obstructed meibomian glands, Demodex blepharitis, incomplete eyelid closure, chronic inflammation or abnormal corneal nerve signaling.
A comprehensive evaluation helps determine whether an important contributor has been overlooked or whether several conditions need to be treated simultaneously.
Learn more: Why Aren’t Artificial Tears Helping My Dry Eyes?
Contact an eye care professional promptly if you experience:
These symptoms may indicate an urgent condition that requires immediate evaluation rather than a routine dry eye appointment.
A comprehensive dry-eye evaluation can help determine whether your symptoms are caused by tear film deficiencies, eyelid disease, ocular surface abnormalities, systemic contributors or a combination of factors.
The goal is to move beyond temporary symptom relief and develop an individualized plan directed at the findings affecting your eyes.
EnVision Dry Eye Center
3752 E Amity Avenue, Suite 103
Nampa, Idaho 83687
Call (208) 490-8823
Request a Comprehensive Dry-Eye Evaluation
Medically reviewed by Jason Besecker, OD, MS
Last updated: October 2026
Explore Dry Eye Questions & Answers